WinSanTor Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • Crowdfunding

  • Latest Deal Amount
  • $707K

  • Investors
  • 6

WinSanTor General Information

Description

Operator of a biotechnology company intended to develop treatments for peripheral neuropathy. The company's biotechnology development discovers a novel pathway resulting in neuroprotection and neuroregeneration of degenerating neurons and patents the new formulation with novel indications, enabling patients to prevent and reverse nerve damage caused by diabetes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 7220 Trade Street
  • Suite 370
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 7220 Trade Street
  • Suite 370
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

WinSanTor Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Equity Crowdfunding 01-Apr-2024 $707K Completed Clinical Trials - Phase 3
13. Later Stage VC 31-Dec-2021 Completed Clinical Trials - Phase 3
12. Grant 01-Sep-2021 Completed Clinical Trials - Phase 3
11. Grant 30-Sep-2020 Completed Clinical Trials - Phase 2
10. Accelerator/Incubator 01-Jan-2020 Completed Clinical Trials - Phase 2
9. Secondary Transaction - Private Completed Clinical Trials - Phase 2
8. Equity Crowdfunding 20-Mar-2019 Completed Clinical Trials - Phase 2
7. Grant 20-Sep-2018 Completed Clinical Trials - Phase 1
6. Later Stage VC 16-Nov-2017 $1.35M $1.35M Completed Clinical Trials - Phase 1
5. Grant 23-May-2017 $3.71M Completed Pre-Clinical Trials
To view WinSanTor’s complete valuation and funding history, request access »

WinSanTor Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view WinSanTor’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

WinSanTor Patents

WinSanTor Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023207084-A1 Compositions and methods for improving sexual sensory disorders Pending 16-Jan-2022
EP-4463234-A1 Compositions and methods for improving sexual sensory disorders Pending 16-Jan-2022
EP-4463234-A4 Compositions and methods for improving sexual sensory disorders Pending 16-Jan-2022
US-20240358712-A1 Compositions and methods for improving sexual sensory disorders Pending 16-Jan-2022
WO-2023137098-A1 Compositions and methods for improving sexual sensory disorders Inactive 16-Jan-2022 A61K31/5513
To view WinSanTor’s complete patent history, request access »

WinSanTor Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

WinSanTor Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Methuselah Foundation Not-For-Profit Venture Capital Minority
CONNECT (San Diego) Accelerator/Incubator Minority
Angel (individual) Minority
Methuselah Fund Venture Capital Minority
Thynk Capital Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

WinSanTor FAQs

  • When was WinSanTor founded?

    WinSanTor was founded in 2011.

  • Where is WinSanTor headquartered?

    WinSanTor is headquartered in San Diego, CA.

  • What is the size of WinSanTor?

    WinSanTor has 16 total employees.

  • What industry is WinSanTor in?

    WinSanTor’s primary industry is Drug Discovery.

  • Is WinSanTor a private or public company?

    WinSanTor is a Private company.

  • What is WinSanTor’s current revenue?

    The current revenue for WinSanTor is .

  • How much funding has WinSanTor raised over time?

    WinSanTor has raised $2.66M.

  • Who are WinSanTor’s investors?

    Methuselah Foundation, CONNECT (San Diego), , Methuselah Fund, and Thynk Capital are 5 of 6 investors who have invested in WinSanTor.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process